Description: Pazufloxacin Mesylate (T-3761), the mesylate salt of Pazufloxacin, is a fluoroquinolone-class antibiotic with a broad spectrum of antibacterial activity against systemic, pulmonary, and urinary tract infections with gram-positive and gram-negative bacteria, including quinolone-resistant Serratia marcescens and Pseudomonas aeruginosa.
Physicochemical Properties
Molecular Formula | C17H19FN2O7S |
Molecular Weight | 414.4044 |
Exact Mass | 414.089 |
Elemental Analysis | C, 49.27; H, 4.62; F, 4.58; N, 6.76; O, 27.03; S, 7.74 |
CAS # | 163680-77-1 |
Related CAS # | Pazufloxacin;127045-41-4 |
PubChem CID | 6918232 |
Appearance | Solid powder |
Boiling Point | 531.5ºC at 760 mmHg |
Melting Point | >255°C (dec.) |
Flash Point | 275.2ºC |
Vapour Pressure | 4E-12mmHg at 25°C |
LogP | 3.025 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 2 |
Heavy Atom Count | 28 |
Complexity | 695 |
Defined Atom Stereocenter Count | 1 |
SMILES | O=C(C(C1=O)=CN2[C@@H](C)COC3=C(C4(N)CC4)C(F)=CC1=C23)O.CS(=O)(O)=O |
InChi Key | UDHGFPATQWQARM-FJXQXJEOSA-N |
InChi Code | InChI=1S/C16H15FN2O4.CH4O3S/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)221-5(2,3)4/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)1H3,(H,2,3,4)/t7-/m0./s1 |
Chemical Name | (S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid compound with methanesulfonic acid (1 |
Synonyms | Pazufloxacin Mesylate; Pazucross; Pasil; T-3762; T 3762; T3762 |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
References |
[1].Fukuoka, Y., et al., In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrob Agents Chemother, 1993. 37(3): p. 384-92. [2].Muratani, T., M. Inoue, and S. Mitsuhashi, In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother, 1992. 36(10): p. 2293-303. |
Solubility Data
Solubility (In Vitro) |
DMSO : ~100 mg/mL (~241.31 mM ) H2O : ≥ 100 mg/mL (~241.31 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.03 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.03 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (6.03 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 10% DMSO+40% PEG300+5% Tween-80+45% Saline: ≥ 2.5 mg/mL (6.03 mM) Solubility in Formulation 5: 150 mg/mL (361.96 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.4131 mL | 12.0656 mL | 24.1313 mL | |
5 mM | 0.4826 mL | 2.4131 mL | 4.8263 mL | |
10 mM | 0.2413 mL | 1.2066 mL | 2.4131 mL |